Intraosseous Infusion Devices Market Size, Share, Growth, and Industry Analysis, By Types (Manual intraosseous infusion devices, Automatic intraosseous infusion devices), By Applications Covered (Hospitals, Ambulatory Surgical Centres, Cardiac Care Centres, Others), Regional Insights and Forecast to 2035

Intraosseous Infusion Devices Market Size

The Global Intraosseous Infusion Devices Market is growing slowly, with the market valued at USD 4,387.9 million in 2025 and expected to reach USD 4,390.5 million in 2026, showing a small year-on-year growth of around 0.058%. The market is further projected to reach nearly USD 4,393 million by 2027, supported by steady demand from emergency and critical care settings, where more than 52% of trauma and cardiac arrest cases use intraosseous access when intravenous access is not possible. By 2035, the Global Intraosseous Infusion Devices Market is expected to reach around USD 4,413.5 million, growing at a CAGR of 0.058% during 2026–2035. Growth is supported by the expansion of emergency response systems, which affects over 48% of hospital purchasing decisions, while device reliability remains above 90% across acute care settings.

The U.S. Intraosseous Infusion Devices Market is expected to witness substantial growth, driven by increasing demand in emergency medical procedures, advancements in device technology, and a rising focus on patient outcomes, ultimately contributing to market expansion.

Intraosseous infusion devices are essential for rapid vascular access, especially in emergency situations where intravenous access is challenging. These devices are inserted into the bone marrow, allowing for the swift administration of fluids and medications directly into the bloodstream. The market for these devices is expanding due to the increasing prevalence of cardiovascular diseases, a growing geriatric population, and advancements in medical technology. Notably, the manual IO needles segment accounted for 49.4% of the market share in 2023, highlighting their widespread use in emergency medical procedures.

Intraosseous Infusion Devices Market Trends

The intraosseous infusion devices market is experiencing significant growth, driven by several key factors. The increasing prevalence of cardiovascular diseases is a major contributor to this trend. According to the World Health Organization, cardiovascular diseases cause 17.9 million deaths annually worldwide, with 4 out of 5 of these deaths resulting from strokes and heart attacks. Additionally, approximately 30% of these deaths occur in individuals under 70 years of age.

The aging global population further exacerbates the demand for intraosseous infusion devices. In the United States, the number of individuals aged 65 and above is projected to increase from 58 million in 2022 to 82 million by 2050, accounting for nearly 23% of the population. This demographic shift is expected to drive the need for advanced medical interventions, including intraosseous infusion devices.

Technological advancements in intraosseous infusion devices are also propelling market growth. For instance, in June 2023, Teleflex Incorporated received 510(k) U.S. FDA clearance for the Arrow EZ-10 IO needle with MR conditional labeling. This device features a diamond tip for precise, fast, and steady insertion, enhancing the efficiency and safety of emergency medical procedures.

Intraosseous Infusion Devices Market Dynamics

The dynamics of the intraosseous infusion devices market are heavily influenced by both technological innovations and the increasing demand for quick and effective emergency treatments. Factors such as the rising number of emergency care cases, including trauma, cardiac arrest, and pediatric emergencies, are significant drivers. As healthcare systems continue to prioritize rapid response times and improved patient outcomes, the importance of intraosseous infusion devices has never been more evident. Moreover, the rise of minimally invasive devices and an increasing preference for user-friendly, automated tools in emergency medical care are propelling market growth. The development of portable, easy-to-use intraosseous infusion devices is expected to further fuel adoption rates in field care and pre-hospital settings, where quick intervention is essential. Regulatory agencies are also playing a role in ensuring the safety and efficacy of these devices, promoting market trust and encouraging further investments in the technology.

Drivers of Market Growth

"Growing Adoption in Emergency Medicine"

The rising adoption of intraosseous infusion devices is largely attributed to their growing use in emergency medicine. In trauma cases, where intravenous access is either challenging or time-consuming, these devices provide a rapid solution for fluid and drug delivery. Their ability to provide life-saving treatments in critical moments has led to widespread adoption in emergency departments, trauma centers, and paramedic teams. As the global population ages, with an increasing number of elderly individuals requiring emergency care, the demand for quick, efficient infusion solutions continues to rise. Moreover, intraosseous infusion devices are becoming increasingly essential in pediatric care, where difficulty in establishing IV access is a common challenge. This trend is further reinforced by advancements in device design, making them safer and easier for healthcare providers to use.

Market Restraints

"High Cost of Advanced Devices"

Despite the increasing adoption of intraosseous infusion devices, high upfront costs associated with some advanced models act as a barrier for hospitals and clinics, especially in low-budget healthcare settings. The cost of training medical personnel to effectively use these devices also contributes to the financial burden. Additionally, the maintenance costs of certain high-tech intraosseous infusion systems can deter smaller healthcare facilities from investing in them. The lack of widespread availability in resource-constrained regions poses another challenge to the global expansion of intraosseous infusion devices. These factors are limiting market penetration in certain areas, despite the device's potential to save lives in emergency medical situations.

Market Opportunities

"Expanding in Emerging Markets"

The intraosseous infusion devices market has promising growth opportunities in emerging markets, where healthcare infrastructure is rapidly improving. With an increasing number of hospitals and emergency medical services being established in regions such as Asia Pacific, Latin America, and the Middle East, there is a rising demand for modern medical technologies. The growing awareness of intraosseous infusion devices and their role in saving lives in critical emergencies is driving the adoption of these devices. Additionally, governments and healthcare organizations in developing countries are investing in modern medical equipment, further boosting the market. Companies that offer affordable, portable, and user-friendly solutions are likely to see strong growth in these regions, especially as the need for rapid, efficient medical interventions continues to increase.

Market Challenges

"Limited Awareness in Certain Regions"

One of the key challenges facing the intraosseous infusion devices market is the lack of awareness and adoption in certain regions, particularly in rural and underserved areas. While these devices are highly effective in emergency situations, many healthcare providers in less developed or resource-limited regions are not fully aware of their capabilities. This results in a slower adoption rate, even though the devices could save lives in critical scenarios. Additionally, the training required for healthcare professionals to properly use intraosseous infusion devices adds another layer of complexity. The scarcity of skilled personnel in some parts of the world may further delay the proper usage and, consequently, the global market growth. Moreover, healthcare systems with limited budgets may struggle to prioritize advanced devices, making it difficult to expand these technologies into areas where they are most needed.

Segmentation Analysis

The intraosseous infusion devices market can be segmented based on type and application, each contributing uniquely to the growth of the market. The segmentation allows for a more targeted analysis of specific needs and preferences across various regions and healthcare settings. In terms of types, manual and automatic intraosseous infusion devices are the two key categories, each with distinct advantages in different emergency scenarios. On the application side, the market is primarily divided into hospitals, ambulatory surgical centers, and cardiac care centers. As healthcare facilities evolve and expand their offerings, the demand for effective infusion devices continues to grow. Understanding these segments helps manufacturers tailor products and solutions to meet the unique demands of each application, ensuring that intraosseous infusion devices fulfill their critical role in patient care.

By Type

• Manual Intraosseous Infusion Devices: Manual intraosseous infusion devices are designed to be operated by healthcare professionals through direct intervention. These devices are typically more affordable and simple to use, making them suitable for environments where speed and reliability are crucial, such as emergency rooms and pre-hospital settings. While they require manual operation to insert the needle and administer fluids or medications, manual devices are still widely preferred for their simplicity and effectiveness in emergency situations. They are commonly used by paramedics and emergency responders who need rapid access to the bloodstream. However, the manual nature of these devices can sometimes lead to variability in outcomes, depending on the skill level of the operator.

• Automatic Intraosseous Infusion Devices: Automatic intraosseous infusion devices represent the more advanced category, with features that streamline the insertion process. These devices are designed to reduce human error by automating the needle insertion process, thus improving speed, accuracy, and patient safety. Automatic devices are particularly beneficial in high-stress environments, where even a small mistake can have significant consequences. They are increasingly being adopted in hospital settings and trauma care, where precision and efficiency are critical. These devices are also ideal for use in situations where time is a crucial factor, such as during cardiac arrest or severe trauma. The higher cost of automatic devices is balanced by the added convenience and reduced risk of complications, driving their growing popularity in advanced healthcare facilities.

By Application

• Hospitals: Hospitals are the largest application segment for intraosseous infusion devices. These devices play a crucial role in emergency departments and intensive care units (ICUs) where rapid fluid and medication administration can significantly impact patient survival. In hospitals, intraosseous infusion devices are utilized in trauma care, critical care, and pediatric emergency settings, where traditional intravenous access may not be feasible. The growing complexity of hospital emergency cases, combined with the rising demand for effective and immediate care, drives the increasing use of intraosseous infusion devices. Hospitals are also investing in more automated and user-friendly devices, as these enhance the efficiency of emergency medical teams and help improve patient outcomes.

• Ambulatory Surgical Centres: Ambulatory surgical centers (ASCs) are increasingly adopting intraosseous infusion devices as part of their emergency preparedness plans. These centers, which provide same-day surgical care and outpatient procedures, are often equipped to handle unexpected medical emergencies such as cardiac arrest, severe trauma, or respiratory failure. In these situations, having an intraosseous infusion device on hand can mean the difference between life and death. The use of these devices in ASCs is also fueled by the growing trend of minimally invasive surgical procedures, where quick access to fluids and medications is often necessary to stabilize patients during surgery. The adoption rate in ASCs is likely to continue growing as the demand for outpatient and day surgeries rises.

• Cardiac Care Centres: Cardiac care centers represent another key application segment for intraosseous infusion devices. Patients suffering from heart attacks, cardiac arrests, or other life-threatening cardiovascular conditions require immediate medical intervention, where quick access to intravenous lines can be difficult. In these settings, intraosseous infusion devices are used to deliver fluids, medications, and other interventions quickly. The demand for these devices in cardiac care centers is rising as these centers increasingly adopt advanced technologies to improve patient outcomes. In cases of cardiac arrest, where every second counts, the ability to swiftly administer life-saving drugs and fluids via intraosseous infusion is critical. The growing number of cardiovascular diseases worldwide further fuels the demand for intraosseous infusion devices in this specialized application area.

Regional Outlook

The intraosseous infusion devices market has a broad geographical reach, with regions experiencing varying growth trends and adoption rates. North America leads in terms of market share, driven by advanced healthcare systems and high demand for rapid emergency care. Europe follows closely, with significant developments in healthcare infrastructure, particularly in countries like the UK, Germany, and France. The Asia-Pacific region is anticipated to see considerable growth, driven by improving healthcare infrastructure and a rising number of emergency medical cases. Meanwhile, the Middle East and Africa are expected to witness steady growth, supported by investments in healthcare facilities and an increasing focus on emergency medical technologies.

North America

North America remains the dominant region in the intraosseous infusion devices market, accounting for the largest market share due to the presence of established healthcare infrastructure and high awareness levels regarding emergency medical procedures. The United States, in particular, is the leading market, with widespread adoption of intraosseous infusion devices in hospitals, emergency medical services, and trauma centers. The robust healthcare system in the region supports advanced technologies, making the adoption of intraosseous infusion devices more widespread. Furthermore, North American countries have a high incidence of trauma cases, cardiovascular diseases, and pediatric emergencies, driving the demand for these devices.

Europe

Europe is a significant player in the intraosseous infusion devices market, with countries like Germany, France, and the UK at the forefront of healthcare innovation and adoption of new technologies. The market growth is fueled by advancements in medical technology, an aging population, and increasing emergency care requirements. European healthcare systems are highly efficient, and there is a growing focus on improving patient outcomes in trauma, critical care, and emergency settings. The European market also benefits from strong regulatory frameworks that promote the use of safe and effective emergency medical devices, further accelerating the adoption of intraosseous infusion devices in the region.

Asia-Pacific

The Asia-Pacific region is expected to see significant growth in the intraosseous infusion devices market, driven by improving healthcare infrastructure and increasing demand for emergency medical services. Countries like China, India, and Japan are investing heavily in upgrading their healthcare systems, which is expected to drive the demand for advanced medical devices, including intraosseous infusion devices. The region also has a high incidence of trauma cases and a growing aging population, further contributing to the demand for rapid medical interventions. With increasing awareness and adoption of modern healthcare technologies, the Asia-Pacific market is poised for strong growth in the coming years.

Middle East & Africa

The Middle East & Africa region is witnessing steady growth in the intraosseous infusion devices market, primarily due to improving healthcare infrastructure and increasing healthcare investments in the region. Countries in the Middle East, including Saudi Arabia and the UAE, are focusing on expanding their healthcare services, especially in trauma and emergency care. The rising number of medical procedures and growing awareness of advanced emergency care methods are contributing to market expansion. In Africa, while the adoption rate is slower, there is an increasing focus on improving emergency care, and intraosseous infusion devices are becoming more common in hospitals and emergency medical services.

List of Key Intraosseous Infusion Devices Market Companies Profiled

• BD
• Cook Medical
• Pyng Medical
• PerSys Medical
• Teleflex
• PAVmed
• Biopsybell

Top Companies with Highest Share

• BD: BD is a leading player in the intraosseous infusion devices market, holding a substantial share due to its comprehensive range of advanced infusion products and strong distribution network.
•  
• Cook Medical: Cook Medical is another top company in this market, known for its innovative intraosseous infusion devices used in critical emergency care situations.

Investment Analysis and Opportunities

The intraosseous infusion devices market presents numerous investment opportunities, especially with the growing demand for emergency care technologies across the globe. The increasing prevalence of trauma cases, cardiovascular diseases, and pediatric emergencies has significantly boosted the market's growth potential. Investors are keen to support companies that are developing more efficient, user-friendly, and cost-effective devices. In developed regions such as North America and Europe, hospitals and emergency medical services are continuously upgrading their equipment, presenting substantial opportunities for companies to expand their presence. Additionally, emerging markets in Asia-Pacific and the Middle East & Africa offer significant growth opportunities as healthcare infrastructure improves and the demand for rapid medical intervention rises. As these regions adopt more advanced emergency medical technologies, there is a growing need for reliable intraosseous infusion devices, driving the market's attractiveness to investors. Furthermore, partnerships and collaborations between medical device manufacturers and healthcare providers can further boost market penetration, ensuring the availability of these devices in a variety of healthcare settings.

New Products Development

The intraosseous infusion devices market is seeing significant new product development aimed at enhancing patient care and improving the efficiency of emergency medical treatments. Manufacturers are focusing on creating more compact, portable, and user-friendly devices to meet the demands of emergency medical teams. For instance, several companies have introduced devices with automatic insertion features that reduce human error and improve the speed of the procedure. Additionally, some new devices are designed with pediatric and geriatric patients in mind, offering features tailored to these vulnerable populations. Companies are also incorporating advanced materials and technologies into their products to make them safer, more durable, and less likely to cause complications. The emphasis on innovation is helping to drive market growth, as hospitals, emergency services, and trauma centers increasingly rely on these advanced devices to deliver critical care.

Recent Developments by Manufacturers in Intraosseous Infusion Devices Market

• BD introduced a new intraosseous infusion device in 2023, designed with improved safety features, making it easier for emergency medical personnel to use with minimal training.
• Teleflex launched a next-generation automatic intraosseous infusion device in early 2024, featuring enhanced precision and a faster response time, improving patient outcomes in emergency settings.
• Cook Medical released a portable version of its intraosseous infusion device in late 2023, catering to pre-hospital care units and emergency medical services in remote locations.
• PerSys Medical unveiled a compact intraosseous infusion system in 2024, specifically designed for pediatric trauma care, ensuring swift intervention in young patients during emergencies.
• Pyng Medical made significant updates to its intraosseous infusion devices in 2023, focusing on ease of use, ergonomic design, and better integration with modern medical equipment.
• Report Coverage of Intraosseous Infusion Devices Market

This report covers detailed insights into the intraosseous infusion devices market, including market dynamics, key drivers, challenges, and opportunities. It provides a comprehensive analysis of market trends, segmentation by type and application, and regional outlook, with a focus on North America, Europe, Asia-Pacific, and the Middle East & Africa. The report includes the competitive landscape, profiling key players in the market, such as BD, Cook Medical, Teleflex, and others, highlighting their strategies, product offerings, and market share. The report also covers key technological advancements and innovations in the intraosseous infusion devices sector, offering valuable insights for stakeholders and potential investors. By examining recent market developments, regulatory trends, and emerging opportunities, the report offers a forward-looking perspective on the future of the intraosseous infusion devices market.